Press release
FeNO Measuring Device Market to Reach USD 615.2 Million by 2034
FeNO Measuring Device
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/48362
Key Takeaways
• The market was valued at USD 236.8 million in 2024, indicating strong growth potential through 2034.
• Portable FeNO devices are witnessing the highest demand, particularly in homecare and telehealth applications.
• North America currently holds the largest market share, followed by Europe, due to advanced respiratory care infrastructure.
• Key manufacturers include Circassia Pharmaceuticals, Bedfont Scientific Ltd., Bosch Healthcare Solutions, NIOX Group plc, and Spirosure Inc.
• Increasing use of FeNO testing in asthma management and clinical trials is expanding market adoption.
Market Story
Fractional Exhaled Nitric Oxide (FeNO) measurement has emerged as a critical biomarker for diagnosing and managing asthma and other eosinophilic airway inflammations. As clinicians aim for precision-based treatment, FeNO testing is becoming an integral part of respiratory care protocols globally.
Technological progress, such as handheld, real-time analyzers with wireless data transfer, has significantly enhanced diagnostic accuracy and patient monitoring convenience. Moreover, the growing integration of FeNO measurement with digital health platforms and telemedicine is transforming how clinicians track patient outcomes remotely.
Market Segmentation
By Type:
• Handheld FeNO Devices
• Desktop FeNO Devices
By Application:
• Asthma Diagnosis and Monitoring
• Chronic Obstructive Pulmonary Disease (COPD)
• Research and Clinical Studies
• Others
By End User:
• Hospitals and Clinics
• Homecare Settings
• Diagnostic Centers
• Research Institutions
By Region:
• North America (U.S., Canada)
• Europe (Germany, UK, France, Italy, Spain)
• Asia-Pacific (China, Japan, India, South Korea, Australia)
• Latin America (Brazil, Mexico)
• Middle East & Africa
Explore Full Report here: https://exactitudeconsultancy.com/reports/48362/feno-measuring-device-market
Recent Developments
• 2025: Circassia Pharmaceuticals launched NIOX VERO 2, a compact, AI-enabled FeNO monitor with cloud connectivity.
• 2024: Bosch Healthcare Solutions introduced a Bluetooth-integrated FeNO analyzer for real-time digital health platforms.
• 2023: Bedfont Scientific Ltd. expanded its NObreath® FeNO device distribution network across Asia-Pacific.
• 2022: Spirosure Inc. partnered with hospitals in Europe for pilot telehealth integration of FeNO testing.
Expert Insight
"With respiratory diseases like asthma and COPD on the rise, FeNO devices are revolutionizing diagnosis and patient monitoring," said Irfan Tamboli, Business Development Executive at Exactitude Consultancy. "The integration of wireless technology and telehealth support makes these devices a crucial part of the evolving connected healthcare ecosystem."
Get Your Exclusive Offer with up to 10% Discount : https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=48362
Market Drivers
1. Increasing global prevalence of asthma and allergic airway diseases.
2. Growing adoption of non-invasive, point-of-care diagnostic tools.
3. Technological advancements in portable and digital FeNO monitors.
4. Expanding clinical applications in pediatric and home-based care.
Forecast & Regional Insights
The North American market dominates due to advanced diagnostic infrastructure and reimbursement support for asthma testing. Europe follows closely, driven by clinical awareness and government healthcare programs. The Asia-Pacific region is projected to grow at the fastest pace (CAGR 11.3%) due to increasing healthcare investments and large patient populations in India and China.
Conclusion
The FeNO Measuring Device Market is experiencing strong momentum as healthcare systems worldwide prioritize early diagnosis and personalized management of respiratory diseases. With continuous innovation in portable, connected, and AI-driven devices, the market is expected to expand significantly over the next decade.
This report is also available in the following languages : Japanese (FeNO測定装置), Korean (FeNO 측정 장치), Chinese (FeNO测量装置), French (Dispositif de mesure du FeNO), German (FeNO-Messgerät), and Italian (Dispositivo di misurazione FeNO), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/reports/48362/feno-measuring-device-market#request-a-sample
Related Reports
Handheld FeNO Breath Analyzers Market
https://exactitudeconsultancy.com/reports/59240/global-handheld-feno-breath-analyzers-market
Fenoldopam Mesylate Injection Market
https://exactitudeconsultancy.com/reports/66385/fenoldopam-mesylate-injection-market
Alcohol Breathalyzer and Drug Testing Equipment Market
https://exactitudeconsultancy.com/reports/75979/alcohol-breathalyzer-and-drug-testing-equipment-market
Breath Analyser Market
https://exactitudeconsultancy.com/reports/66472/breath-analyser-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release FeNO Measuring Device Market to Reach USD 615.2 Million by 2034 here
News-ID: 4261115 • Views: …
More Releases from Exactitude Consultancy
Bevacizumab Biosimilars Market to Set Phenomenal Growth From 2025 to 2034
Bevacizumab, a monoclonal antibody that inhibits vascular endothelial growth factor (VEGF), is used primarily in the treatment of various cancers, including colorectal cancer, lung cancer, breast cancer, and renal cell carcinoma. It works by preventing the growth of blood vessels that supply tumors, thus inhibiting tumor growth. However, as the patent for bevacizumab has expired, biosimilars of bevacizumab are gaining significant attention as cost-effective alternatives to the original branded drug.
Download…
Ocular Drug Delivery Devices Market is Set to Experience a Revolutionary Growth
The ocular drug delivery devices market is focused on technologies and devices that allow for the efficient and controlled delivery of drugs to the eye. These devices are essential for treating various eye diseases, including glaucoma, age-related macular degeneration (AMD), diabetic retinopathy, and dry eye disease. Effective ocular drug delivery is critical, as the eye presents unique challenges for drug absorption due to its anatomical structure, including the blood-retinal barrier…
mRNA Market to Set Phenomenal Growth From 2025 to 2034
Messenger RNA (mRNA) technology has revolutionized the landscape of drug development, particularly in the field of vaccines and therapeutic treatments. mRNA serves as a template for protein synthesis, enabling cells to produce proteins that can trigger an immune response or directly treat diseases. While mRNA technology has been around for years, its potential has been dramatically highlighted with the success of mRNA-based COVID-19 vaccines, such as those developed by Pfizer-BioNTech…
PERK Inhibitors Market is Set to Experience a Revolutionary Growth
PERK (Protein Kinase RNA-like Endoplasmic Reticulum Kinase) is a key enzyme involved in the unfolded protein response (UPR), a cellular stress response mechanism that helps cells deal with the accumulation of misfolded proteins in the endoplasmic reticulum (ER). When cellular stress occurs, PERK activation helps alleviate the burden by regulating protein synthesis and activating stress-related pathways. However, dysregulation of PERK can contribute to the development of various diseases, including cancer,…
More Releases for FeNO
FeNO Breath Analyzer Market - Global Industry Perspective Comprehensive Analysis …
The global market for FeNO Breath Analyzer was estimated to be worth US$ 115 million in 2024 and is forecast to a readjusted size of US$ 270 million by 2031 with a CAGR of 13.3% during the forecast period 2025-2031.
QYResearch (Global Market Report Research Publisher) announces the release of 2025 latest report "FeNO Breath Analyzer - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031". Based on current…
FeNO Breath Analyzer Market Outlook and Future Projections for 2030
The feno breath analyzer market represents a dynamic and continually evolving landscape, shaped by changing consumer demands and technological advancements. In this comprehensive report, we provide an in-depth exploration of the market, designed for a wide range of stakeholders including manufacturers, suppliers, distributors, and investors. Our goal is to equip industry participants with essential insights that enable informed decision-making in an ever-changing market environment. This analysis not only examines the…
Handheld FeNO Breath Analyzers Market Trends, Demand, and Future Outlook
Exactitude Consultancy., Ltd. announces the release of the report "Global Handheld FeNO Breath Analyzers Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2034". The report is a detailed and comprehensive analysis presented by region and country, type and application. As the market is constantly changing, the report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets.…
China FeNO Testing Market Size Worth USD 66,564.09 million by 2030| China FeNO T …
A FeNO test or exhaled nitric oxide test can be used to determine how much lung inflammation is present and how well inhaled steroids are suppressing this inflammation in patients with allergic or eosinophilic asthma. FeNO testing is a quantitative, non-invasive, simple, and safe test that can be performed in primary care by a properly trained health care professional who is competent to deliver and interpret the results. The advantages…
China FeNO Testing Market Forecast & Insight 2030
A FeNO test or exhaled nitric oxide test can be used to determine how much lung inflammation is present and how well inhaled steroids are suppressing this inflammation in patients with allergic or eosinophilic asthma. FeNO testing is a quantitative, non-invasive, simple, and safe test that can be performed in primary care by a properly trained health care professional who is competent to deliver and interpret the results. The advantages…
FeNO Measuring Device Market Trends Analysis, Demand and Forecasts 2030
A recent market research report added to repository of Analytics Market Research is an in-depth analysis of Global & USA FeNO Measuring Device Market. On the basis of historic growth analysis and current scenario of FeNO Measuring Device market place, the report intends to offer actionable insights on Global & USA market growth projections. Authenticated data presented in report is based on findings of extensive primary and secondary research. Insights…
